Evidence mapPaperPMID 42074039Full record

Observational studyInternational journal of molecular sciences2026

Differential Expression of microRNAs in Obese Mexican Children: Links to Insulin Resistance and Dyslipidemia.

Alejandra Contreras-Ramos, Guadalupe Díaz-Rosas, Miguel Cruz, Ana Nava-Cabrera, Miguel Vazquez-Moreno, Omar Gómez-Acuña, Ana María Guerrero-Ortiz, Carmen Domínguez-Hernández, Aleyda Pérez-Herrera, Rosalinda Jiménez-Aguilar and 5 more

Abstract readObservational Study
In one paragraph

Observational study in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alejandra Contreras-RamosLaboratorio de Investigación en Biología Molecular, Hospital Infantil de México Federico Gómez (HIMFG), Ciudad de México 06720, Mexico.ORCID 0000-0002-5173-9927
Guadalupe Díaz-RosasLaboratorio de Investigación en Biología Molecular, Hospital Infantil de México Federico Gómez (HIMFG), Ciudad de México 06720, Mexico.ORCID 0000-0002-5370-5771
Miguel CruzUnidad de Investigación Médica en Bioquímica, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México 06720, Mexico.ORCID 0000-0001-9985-6172
Ana Nava-CabreraUnidad de Investigación Médica en Bioquímica, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México 06720, Mexico.ORCID 0009-0008-5512-7224
Miguel Vazquez-MorenoUnidad de Investigación Médica en Bioquímica, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México 06720, Mexico.ORCID 0000-0002-9170-0488
Omar Gómez-AcuñaLaboratorio de Investigación en Biología Molecular, Hospital Infantil de México Federico Gómez (HIMFG), Ciudad de México 06720, Mexico.ORCID 0009-0009-1768-9952
Ana María Guerrero-OrtizLaboratorio de Investigación en Biología Molecular, Hospital Infantil de México Federico Gómez (HIMFG), Ciudad de México 06720, Mexico.
Carmen Domínguez-HernándezOOAD Campeche, Coordinación de Planeación y Enlace Institucional, Instituto Mexicano del Seguro Social, Campeche 24010, Mexico.
Aleyda Pérez-HerreraMéxico SECIHTI, CIIDIR-Unidad Oaxaca, Instituto Politécnico Nacional, Santa Cruz Xoxocotlán 71233, Mexico.ORCID 0000-0002-2616-536X
Rosalinda Jiménez-AguilarUnidad Médica de Alta Especialidad, Hospital General Gaudencio González de la Garza, Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social, Ciudad de México 02990, Mexico.ORCID 0000-0003-2104-2288
Jaime Goméz-ZamudioUnidad de Investigación Médica en Bioquímica, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México 06720, Mexico.ORCID 0000-0002-4903-2420
Francisco Javier Gaytán-CervantesLaboratorio de Secuenciación, División de Desarrollo de la Investigación en Salud, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México 06720, Mexico.
Miguel Ángel Cid-SotoLaboratorio de Secuenciación, División de Desarrollo de la Investigación en Salud, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México 06720, Mexico.
Carolina González-TorresLaboratorio de Secuenciación, División de Desarrollo de la Investigación en Salud, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México 06720, Mexico.
Clara Ortega-CamarilloUnidad de Investigación Médica en Bioquímica, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México 06720, Mexico.ORCID 0000-0001-8709-6727

Funding

INSTITUTO MEXICANO DEL SEGURO SOCIAL R-2020-785-131SECRETARIAT OF EDUCATION, SCIENCE, TECHNOLOGY AND INNOVATION (SECTEI) SECTEI/162/2023
6 · The paper itself

Abstract

To analyze, in an analytical cross-sectional observational study, the relationship between the plasma microRNA (miRNA) expression profile in children living with obesity and their metabolic health status. Based on body mass index percentiles (BMIp), the children were grouped into a control group (C) or an obesity group (Ob). Glucose, insulin, and low- and high-density lipoproteins (LDLs and HDLs, respectively), triacylglycerols (TG), and total cholesterol (TC) were measured. RNA from plasma was used for miRNA sequencing analysis (NextSeq 2000 platform). Differential miRNA expression was determined using counts obtained from the reference genome. Fifty controls (BMIp: 50.4 ± 23) and fifty children with obesity (BMIp: 97.54 ± 1.46) were included. The obese group presented hyperinsulinemia and insulin resistance. Sequencing revealed nine underexpressed and six overexpressed miRNAs in the obese group. In silico analysis suggested that these miRNAs may participate in regulating insulin secretion, protein synthesis, apoptosis, and the glycolytic pathway in pancreatic β-cells. Childhood obesity was associated with altered circulating levels of microRNAs linked to glucose metabolism, insulin resistance (IR) and β-cell survival. Reduced plasma levels of miR-126-3p, let-7a-5p, and miR-16-5p showed a high predictive value for hypertriglyceridemia and insulin resistance, indicating their potential relevance as early biomarkers or therapeutic targets in pediatric metabolic dysfunction.

Indexed as

DyslipidemiasInsulin ResistanceMicroRNAsObesityPediatric ObesityChildCross-Sectional StudiesFemaleGene Expression RegulationHumansInsulinMaleMexicoInsulinMicroRNAschildhood obesityinsulin resistancemiRNAspancreatic beta cells

Identifiers

PMID42074039
PMCPMC13116648

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.